Nosocomial transmission of Serratia marcescens in a veterinary hospital due to contamination by benzalkonium chloride.

AUTOR(ES)

Fox, J G

RESUMO

During a 1-year period, Serratia marcescens was isolated from 50% of all contaminate intravenous catheters from dogs and cats in a large veterinary hospital. S. marcescens was also isolated from respiratory tracts, genitourinary tracts, skin, and other sites in hospitalized animals. A total of 55% of the clinical isolates and 66% of the intravenous catheter isolates had the same API biochemical profile. The source of the S. marcescens was determined to be aqueous benzalkonium chloride (0.025%) sponge pots located in the intensive care unit, surgery rooms, and outpatient clinic areas of the hospital. Of the 11 S. marcescens isolates submitted to the Centers for Disease Control for serotyping (6 from aqueous benzalkonium chloride sponge pots, 5 from intravenous catheters), 8 were identified as serotype O10:H11. All S. marcescens isolates tested for antibiotic susceptibilities were multiply resistant; isolates were most frequently resistant to streptomycin, cephalothin, and ampicillin. This study demonstrates that improper use of disinfectants plays an important role in the nosocomial transmission of S. marcescens.

Documentos Relacionados

• Epidemic septic arthritis caused by Serratia marcescens and associated with a benzalkonium chloride antiseptic.
• Survival of Serratia marcescens in benzalkonium chloride and in multiple-dose medication vials: relationship to epidemic septic arthritis.
• Ribotyping provides efficient differentiation of nosocomial Serratia marcescens isolates in a pediatric hospital.
• Reduced virulence of Pseudomonas aeruginosa grown in the presence of benzalkonium chloride.
• Fourteen-year survival of Pseudomonas cepacia in a salts solution preserved with benzalkonium chloride.